G Fenelon

Summary

Country: France

Publications

  1. ncbi request reprint Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors
    G Fenelon
    Department of Neurology, Hopital Tenon, Paris, France
    Brain 123:733-45. 2000
  2. doi request reprint Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease
    David Devos
    Department of Neurology, EA2683 IFR114 IMPRT, Hopital R Salengro, CHU Lille, France
    Mov Disord 24:993-1000. 2009

Detail Information

Publications2

  1. ncbi request reprint Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors
    G Fenelon
    Department of Neurology, Hopital Tenon, Paris, France
    Brain 123:733-45. 2000
    ..The main risk factor in treated patients is cognitive impairment, although sleep-wake cycle disturbances, and possibly other factors related to the duration of the disease, act as cofactors...
  2. doi request reprint Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease
    David Devos
    Department of Neurology, EA2683 IFR114 IMPRT, Hopital R Salengro, CHU Lille, France
    Mov Disord 24:993-1000. 2009
    ..Technical problems were commonplace. Duodenal levodopa infusion seems to be an effective last-line therapy for motor complications in Parkinson's disease. Hence, technical improvements and earlier introduction should be considered...